AIM
HAE icon

Aigen Investment Management’s Haemonetics HAE Stock Holding History

Aigen Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
+3,685
New +$237K 0.08% 339
2024
Q4 		– Sell
-5,959
Closed -$479K – 845
2024
Q3 		$479K Buy
+5,959
New +$481K 0.09% 337
2022
Q1 		– Sell
-7,600
Closed -$397K – 764
2021
Q4 		$397K Buy
+7,600
New +$463K 0.02% 700
2020
Q2 		– Sell
-558
Closed -$56K – 999
2020
Q1 		$56K Sell
558
-30,699
-98% -$3.33M 0.01% 965
2019
Q4 		$3.59M Buy
+31,257
New +$3.78M 0.59% 24

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aigen Investment Management's HAE Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Haemonetics (HAE) in Q2 2026: 3,685 shares worth $276K. The stake represents 0.08% of the portfolio and ranks #339 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in HAE as recently as Q3 2024.

Aigen Investment Management first reported a position in HAE in Q4 2019 and has held it in 5 quarters since. The position peaked at $3.59M in Q4 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Aigen Investment Management held 3,685 shares of Haemonetics worth $276K as of Q2 2026.
  • Haemonetics was a new Aigen Investment Management position in Q2 2026.
  • Haemonetics made up 0.08% of Aigen Investment Management's portfolio in Q2 2026, its #339 holding.
  • Aigen Investment Management first reported a position in Haemonetics in Q4 2019 and has held it in 5 quarters since.
  • Aigen Investment Management's Haemonetics position peaked at $3.59M in Q4 2019.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.